Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection.
暂无分享，去创建一个
V. de Lédinghen | P. Angus | K. Reddy | B. Conway | S. Pol | N. Boyer | M. Sulkowski | I. Jacobson | F. Poordad | A. Muir | N. Bräu | E. Tam | Grisell Ortiz-Lasanta | M. Bennett | F. Mcphee | E. Hughes | J. Bronowicki | W. Sievert | Samuel S. Lee | E. Swenson | L. Mollison | E. Tse | P. Yin | N. Boparai | T. Sepe | J. Levin | Samuel S Lee